Validation of genome-wide prostate cancer associations in men of African descent
- PMID: 21071540
- PMCID: PMC3110616
- DOI: 10.1158/1055-9965.EPI-10-0698
Validation of genome-wide prostate cancer associations in men of African descent
Abstract
Background: Genome-wide association studies (GWAS) have identified numerous prostate cancer susceptibility alleles, but these loci have been identified primarily in men of European descent. There is limited information about the role of these loci in men of African descent.
Methods: We identified 7,788 prostate cancer cases and controls with genotype data for 47 GWAS-identified loci.
Results: We identified significant associations for SNP rs10486567 at JAZF1, rs10993994 at MSMB, rs12418451 and rs7931342 at 11q13, and rs5945572 and rs5945619 at NUDT10/11. These associations were in the same direction and of similar magnitude as those reported in men of European descent. Significance was attained at all reported prostate cancer susceptibility regions at chromosome 8q24, including associations reaching genome-wide significance in region 2.
Conclusion: We have validated in men of African descent the associations at some, but not all, prostate cancer susceptibility loci originally identified in European descent populations. This may be due to the heterogeneity in genetic etiology or in the pattern of genetic variation across populations.
Impact: The genetic etiology of prostate cancer in men of African descent differs from that of men of European descent.
©2011 AACR.
Figures
References
-
- Eeles RA, Kote-Jarai Z, Giles GG, et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet. 2008;40:316–21. - PubMed
-
- Thomas G, Jacobs KB, Yeager M, et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet. 2008;40:310–5. - PubMed
-
- Duggan D, Zheng SL, Knowlton M, et al. Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst. 2007;99:1836–44. - PubMed
Publication types
MeSH terms
Grants and funding
- CA54281/CA/NCI NIH HHS/United States
- R01- ES011126/ES/NIEHS NIH HHS/United States
- P50 CA140388/CA/NCI NIH HHS/United States
- R01 CA112028/CA/NCI NIH HHS/United States
- U01 CA086402/CA/NCI NIH HHS/United States
- A7357/CRUK_/Cancer Research UK/United Kingdom
- R01 CA068578/CA/NCI NIH HHS/United States
- R01-CA08574/CA/NCI NIH HHS/United States
- R01 CA063464/CA/NCI NIH HHS/United States
- P50-CA140388/CA/NCI NIH HHS/United States
- R01CA128813/CA/NCI NIH HHS/United States
- R01 ES011126/ES/NIEHS NIH HHS/United States
- R37 CA054281/CA/NCI NIH HHS/United States
- R01CA84979/CA/NCI NIH HHS/United States
- CA88164/CA/NCI NIH HHS/United States
- R01CA112028/CA/NCI NIH HHS/United States
- R01 CA084979/CA/NCI NIH HHS/United States
- CA127298/CA/NCI NIH HHS/United States
- C5047/A7357/CRUK_/Cancer Research UK/United Kingdom
- UO1 CA86402/CA/NCI NIH HHS/United States
- U01 CA127298/CA/NCI NIH HHS/United States
- R03 CA128028/CA/NCI NIH HHS/United States
- P01-CA105641/CA/NCI NIH HHS/United States
- R01 CA056678/CA/NCI NIH HHS/United States
- CA63464/CA/NCI NIH HHS/United States
- P50CA69568/CA/NCI NIH HHS/United States
- P30 CA076292/CA/NCI NIH HHS/United States
- R01 CA054281/CA/NCI NIH HHS/United States
- U01 CA063464/CA/NCI NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- P50 CA105641/CA/NCI NIH HHS/United States
- R01 CA128813/CA/NCI NIH HHS/United States
- R01 CA088164/CA/NCI NIH HHS/United States
- R01 CA092579/CA/NCI NIH HHS/United States
- P50 CA069568/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
